AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Net Block History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Block | ₹14,794 Cr | ₹14,493 Cr | ₹11,024 Cr | ₹10,532 Cr | ₹9,374 Cr |
What is the latest Net Block ratio of AUROBINDO PHARMA ?
Year | Net Block |
---|---|
Mar2025 | ₹14,794 Cr |
Mar2024 | ₹14,493 Cr |
Mar2023 | ₹11,024 Cr |
Mar2022 | ₹10,532 Cr |
Mar2021 | ₹9,374 Cr |
How is Net Block of AUROBINDO PHARMA Trending?
Years | Net Block | % Change | |
---|---|---|---|
Mar2025 | ₹14,794 Cr | 2.08 | |
Mar2024 | ₹14,493 Cr | 31.47 | |
Mar2023 | ₹11,024 Cr | 4.67 | |
Mar2022 | ₹10,532 Cr | 12.36 | |
Mar2021 | ₹9,374 Cr | - |
Compare Net Block of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹63,307.2 Cr | 3.5% | -5.5% | -28.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,667.0 Cr | 1.2% | -4.2% | -5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,697.0 Cr | 3% | -9.1% | 31.5% | Stock Analytics | |
CIPLA | ₹126,365.0 Cr | 4.1% | 5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,639.0 Cr | 1.1% | 4.3% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,479.0 Cr | 3.7% | 0.1% | -7.4% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 3.5% |
-5.5% |
-28.7% |
SENSEX | 1.8% |
-1.7% |
2.9% |
You may also like the below Video Courses